You are here: Industry Insights > Pfizer

News List

Pfizer bags approval for RA drug Xeljanz pharmatimes
March 28, 2017
Some patients with moderate to severe forms of rheumatoid arthritis could get access to a new treatment option in Europe following the approval of Pfizer’s oral Janus kinase (JAK) ...
Pfizer receive European approval for arthritis drug pharmafile
March 28, 2017
Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given European Commission marketing authorisation for treatment of moderate to severe active rheumatoid arthritis (RA).
SutroVax reels in $64M with plans to take on $7B pneumococcal vaccine market fiercepharma
March 22, 2017
Armed with $64 million in new venture funding, San Francisco’s SutroVax is setting out to challenge the world’s biggest target in vaccines, Pfizer’s superstar pneumococcal shot Prevnar 13.
Pfizer CentreOne Expands Service Portfolio contractpharma
March 17, 2017
Adds contract manufacturing of highly potent solid oral dose at Ireland facility
Pfizer launches new antibiotic in the UK and Germany cphi-online
March 16, 2017
Zavicefta treat complicated infections caused By Gram-negative bacteria.
Pfizer announces partnership with UK university pharmafile
March 14, 2017
Pfizer and Swansea University have announced plans to collaborate on a new Innovation Hub at Swansea University’s new £450 million Bay Campus.
The Union for International Cancer Control and Pfizer announce next phase of global grants initiativ worldpharmanews
March 10, 2017
In conjunction with International Women's Day, The Union for International Cancer Control (UICC) and Pfizer Inc. have announced the next phase of their pioneering grants initiative to address the unique challenges facing metastatic breast cancer (mBC) pat
Pfizer Subpoenaed in DOJ Investigation of Drugmaker Charity Connections firstwordpharma
February 27, 2017
Pfizer received two subpoenas from the US Attorney’s office in Massachusetts related to charities that help Medicare patients afford co-payments for drugs, Bloomberg reported
Ronald E. Blaylock elected to Pfizer's Board of Directors worldpharmanews
February 27, 2017
Pfizer Inc. has announced the election of Ronald E. Blaylock to its Board of Directors, effective immediately. Mr. Blaylock was also appointed to the Corporate Governance and Science and Technology Committees of Pfizer's Board.
US FDA accepts regulatory submission for Pfizer’s inotuzumab ozogamicin pharmaceutical-technology
February 24, 2017
US-based pharmaceutical company Pfizer’s biologics licence application (BLA) for inotuzumab ozogamicin has been accepted for filing and granted priority review by the US Food and Drug Administration (FDA).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page